In breast cancer patients, the increase in memory CD4 T and plasma cells seems to be conducive to the prolongation of survival (disease-free survival or overall survival), while the increase in M2 macrophages, activated NK cells, Tregs and activated mast cells is related to the decrease in survival [179,180]. The gene discussed is CD4; the disease is breast carcinoma.